Apraglutide TFA

Send Inquiry
Apraglutide TFA
Details
CAS: No unified CAS number (free base research code: Apraglutide)
Core structure: Long-acting glucagon-like peptide-2 (GLP-2) analog. The 33-mer peptide backbone is modified by site-specific amino acid substitution, significantly enhancing DPP-IV resistance and greatly prolonging in vivo half-life. TFA salt form improves purification efficiency and formulation stability.
We also provide specifications from crude to 99% purity, please contact us for details!
**Related documents**
COA/MS/HPLC Report
Peptide Dissolution and Storage Guide
Category
Pharmaceutical Peptides
Share to
Description

Shanghai Sonyt Biotechnology Co., Ltd. is one of the leading manufacturers and suppliers of apraglutide tfa in China, also supports custom service. Welcome to wholesale bulk high quality apraglutide tfa from our factory. Contact us for more details.

 

Product Name Apraglutide TFA
Description Apraglutide is a long-acting, highly selective GLP-2 receptor agonist. It specifically activates GLP-2 receptors on intestinal epithelial cells, promotes intestinal mucosal epithelial cell proliferation, inhibits apoptosis, enhances intestinal barrier function, and increases intestinal nutrient absorption area. Optimized by sequence modification, it has significantly improved DPP-4 resistance and a much longer in vivo half-life than native GLP-2. It significantly improves intestinal structure and function in models of short bowel syndrome, intestinal mucosal injury and inflammatory bowel disease, serving as a core tool peptide for intestinal metabolic disease mechanism research and peptide drug development.
Peptide Purity (HPLC, %) 95% / 98% / 99%
Free peptide molecular formula C₁₆₈H₂₆₃N₄₇O₅₅
Free peptide molecular weight (Da) 3782.2, higher for TFA salt form
Structure type Linear modified 33-mer peptide, peptidase-resistant site optimization, trifluoroacetate salt

 

Product Basic Information Table

 

Product Standard English Name Product Abbreviation / Alias Function Tags (comma-separated) Core Structure Molecular Formula Exact Mass (Da) Average MW (Da) Salt Form Length (aa)
Apraglutide TFA Long-acting GLP-2 analog GLP-2 receptor agonist, intestinal mucosa repair, enhances intestinal barrier, short bowel syndrome research Long-acting modified 33-mer peptide with site-specific amino acid substitution based on native GLP-2 backbone, significantly enhances DPP-4 resistance and prolongs in vivo half-life. Free base: C₁₆₈H₂₆₃N₄₇O₅₅; Salt form: C₁₆₈H₂₆₃N₄₇O₅₅·xC₂HF₃O₂ 3780.89 (free base) 3782.2 (free base) Trifluoroacetate (TFA) 33

Physicochemical Solubility & Storage Parameters

 

Product Code Appearance Long-term Storage Short-term Storage Solution Stability Solid Powder Stability
PEP-APR001 white powder Store at -20°C, sealed, dry and protected from light. Aliquot to avoid repeated freeze-thaw cycles. -80°C recommended for long-term storage. Stable for 2 months at 2–8°C in sealed dry condition; stable for short-term shipping at ambient temperature. Stable for 7 days at 4°C. Solubility: ~100 mg/mL in DMSO, ~5 mg/mL in water (dilute acetic acid assists dissolution). DPP-4 resistance is significantly superior to native GLP-2. Stable for 2 years at -20°C, dry and protected from light.

Functional Description

 

Product Code Frontend Short Summary (for search list display) Detailed Biological Function Description Applicable Research Areas (comma-separated) Targets / Pathways
PEP-APR001 Long-acting GLP-2 receptor agonist, promotes intestinal mucosa repair and enhances barrier function Apraglutide is a long-acting, highly selective glucagon-like peptide-2 (GLP-2) receptor agonist. It specifically activates GLP-2 receptors on intestinal epithelial cells, drives the downstream cAMP signaling pathway, promotes intestinal crypt cell proliferation, inhibits epithelial cell apoptosis, increases villus height and nutrient absorption area, and enhances intestinal tight junction barrier function. Modified by site-specific amino acid substitution, it has significantly improved DPP-4 resistance and a much longer in vivo half-life than native GLP-2. It significantly improves intestinal structure and function in models of short bowel syndrome, chemotherapy-induced mucositis and inflammatory bowel disease, and is a core tool peptide for intestinal metabolic disease mechanism research and peptide drug development. Short bowel syndrome research, intestinal mucosal injury repair, inflammatory bowel disease study, intestinal barrier function research, metabolic peptide drug development Glucagon-like peptide 2 receptor (GLP-2R); cAMP signaling pathway; Intestinal epithelial proliferation/apoptosis pathway

 

 

 

 

 

 

Hot Tags: apraglutide tfa, China apraglutide tfa manufacturers, suppliers, factory, 137525-51-0, 1566590-77-9, CAS 129954 34 3, Melanotan II, Retatrutide, Semaglutide

Send Inquiry